| 1. | Selva-O'Callaghan A, Romero-Bueno F, Trallero-Araguás E,  et al. Pharmacologic treatment of anti-MDA5 rapidly progressive interstitial lung disease. Curr Treatm Opt Rheumatol, 2021, 7(4): 319-333 . | 
				                                                        
				                                                            
				                                                                | 2. | Lian X, Zou J, Guo Q,  et al. Mortality risk prediction in amyopathic dermatomyositis associated with interstitial lung disease: The FLAIR Model. Chest, 2020, 158(4): 1535-1545. | 
				                                                        
				                                                            
				                                                                | 3. | Warrick JH, Bhalla M, Schabel SI,  et al. High resolution computed tomography in early scleroderma lung disease. J Rheumatol, 1991, 18(10): 1520-1528. | 
				                                                        
				                                                            
				                                                                | 4. | Kang DC, Gopalkrishnan RV, Wu QP,  et al.  mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc Natl Acad Sci U S A, 2002, 99(2): 637-642. | 
				                                                        
				                                                            
				                                                                | 5. | Wang G, Wang Q, Wang YM,  et al. Presence of anti-MDA5 antibody and its value for the clinical assessment in patients with COVID-19: a retrospective cohort study. Front Immunol, 2021, 12: 791348. | 
				                                                        
				                                                            
				                                                                | 6. | Chen ZW, Wang XD, Ye S. Tofacitinib in amyopathic dermatomyositis-associated interstitial lung disease. N Engl J Med, 2019, 381(3): 291-293. | 
				                                                        
				                                                            
				                                                                | 7. | He CJ, Li WY, Xie QB,  et al. Rituximab in the treatment of interstitial lung diseases related to anti-melanoma differentiation-associated gene 5 dermatomyositis: a systematic review. Front Immunol, 2021, 12: 820163. | 
				                                                        
				                                                            
				                                                                | 8. | Szekanecz E, Sándor Z, Antal-Szalmás P,  et al. Increased production of the soluble tumor-associated antigens CA19-9, CA125, and CA15-3 in rheumatoid arthritis: potential adhesion molecules in synovial inflammation?. Ann N Y Acad Sci, 2007, 1108(1): 359-371. | 
				                                                        
				                                                            
				                                                                | 9. | Hammarstr?m S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol, 1999, 9(2): 67-81. | 
				                                                        
				                                                            
				                                                                | 10. | Shi L, Han XL, Guo HX,  et al. Increases in tumor markers are associated with primary Sj?gren's syndrome-associated interstitial lung disease. Ther Adv Chronic Dis, 2020, 11: 2040622320944802. | 
				                                                        
				                                                            
				                                                                | 11. | Zheng MH, Lou AJ, Zhang HR,  et al. Serum KL-6, CA19-9, CA125 and CEA are diagnostic biomarkers for rheumatoid arthritis-associated interstitial lung disease in the Chinese population. Rheumatol Ther, 2021, 8(1): 517-527. | 
				                                                        
				                                                            
				                                                                | 12. | Strieter RM, Mehrad B. New mechanisms of pulmonary fibrosis. Chest, 2009, 136(5): 1364-1370. | 
				                                                        
				                                                            
				                                                                | 13. | Wijsenbeek M, Suzuki A, Maher TM,  et al. Interstitial lung diseases. Lancet, 2022, 400(10354): 769-786. |